-
Owens & Minor Stock to Gain From New Collaboration With Google Cloud
2024 Sep 12, 11:07am | 826Owens & Minor, Inc. (NYSE: OMI) has announced a partnership with Google Cloud, owned by the parent holding company, Alphabet to enhance the existing capabilities of its cloud-based clinical inventory management system, QSight. The collaboration will combine the company's expertise in...
-
Here's Why You Should Buy Kronos Worldwide Stock Right Now
2024 Sep 11, 3:00pm | 835Kronos Worldwide, Inc. (NYSE: KRO) is expected to benefit from higher demand for titanium dioxide (TiO2) and easing pricing pressure this year. Cost-reduction initiatives are also expected to support margins. We are positive about KRO's prospects and believe that the time is right for you to...
-
Paragon 28 Stock Gains From the Latest Launch of Its Right-Angle Drill
2024 Sep 11, 2:33pm | 806Paragon 28, Inc. (NYSE: FNA) recently introduced a novel Right-Angle Drill, designed to improve tibia preparation prior to the implantation of the APEX 3D tibia. The Right-Angle Drill will be an addition to the APEX 3D Total Ankle Replacement System. This recent advancement to the APEX 3D...
-
Reasons to Retain ResMed Stock in Your Portfolio for Now
2024 Sep 11, 2:27pm | 834ResMed Inc.'s (NYSE: RMD) growth is backed by its impressive global Mask sales growth. Of late, the company has been experiencing increased Device sales, reflecting the ongoing combined availability of AirSense 10 and AirSense 11 sleep devices. However, concerns loom over ResMed's...
-
Glaukos Stocks Rides on Strong Product Demand Amid Competition
2024 Sep 11, 2:20pm | 1284Glaukos Corporation (NYSE: GKOS) is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. The strength in the iStent product line and solid execution across its global glaucoma and Corneal Health franchises...
-
Dave & Buster's Analysts See Upside In 'Challenging Environment' After Q2 Earnings Beat
2024 Sep 11, 10:41am | 496Shares of Dave & Buster’s Entertainment Inc (NASDAQ:PLAY) climbed in early trading on Wednesday, after the company reported upbeat second-quarter results. The company reported its results amid an exciting earnings season. Here are some key analyst takeaways. BMO Capital Markets On Dave...
-
Cigna Stock Gains 26% in a Year: What Lies Ahead for Investors?
2024 Sep 10, 3:42pm | 819Shares of The Cigna Group (NYSE: CI) have gained 25.6% in the past year compared with the industry's 18.2% growth. The Medical sector and the S&P 500 composite index have rallied 9.3% and 21.2%, respectively, in the same time frame. CI has been well-poised for growth on the back of a sound...
-
Here's Why You Should Hold Onto Air Products Stock for Now
2024 Sep 10, 2:36pm | 749Air Products and Chemicals, Inc. (NYSE: APD) is expected to gain from its project investments, productivity actions and new business deals amid the softness in China and Europe. The company's shares have lost 9.6% over a year compared with a 10.6% decline of its industry. Image Source: Zacks...
-
Here's Why You Should Retain PDCO Stock in Your Portfolio for Now
2024 Sep 10, 1:50pm | 1083Patterson Companies, Inc. (NASDAQ: PDCO) is well poised for growth in the coming quarters, courtesy of its broad product line. The optimism, led by a strong performance of certain business segments during first-quarter fiscal 2024 and a few notable acquisitions, is expected to contribute further....
-
Will Trinity Biotech Stock Gain From Its Latest Patent Process?
2024 Sep 10, 12:59pm | 925Trinity Biotech plc (NASDAQ: TRIB) recently provided an update on its continued development of its glucose biosensor technology. Earlier this year, the company was granted a European patent for a novel method that enhances the performance of its glucose biosensor. Recent testing of this...
-
Virco's Q2 Earnings Beat Estimates, Revenues Miss, Stock Falls
2024 Sep 10, 11:49am | 836Virco Manufacturing Corporation (NASDAQ: VIRC) reported mixed second-quarter fiscal 2024 (ended July 31, 2024) results, wherein earnings surpassed the Zacks Consensus Estimate but sales missed the same. Following the results, the company's shares lost 9.3% on Sept. 09. On a year-over-year basis...
-
Oracle Analysts Focus On AI-Driven Bookings Strength, Expect Revenue Acceleration To Continue
2024 Sep 10, 10:54am | 882Shares of Oracle Corp (NYSE:ORCL) climbed in early trading on Tuesday, after the company reported upbeat fiscal first-quarter results. The company reported its results amid an exciting earnings season. Here are some key analyst takeaways. JMP Securities analyst Patrick Walravens upgraded the...
-
Rocket Stock Down More Than 30% in Past Six Months: Here's Why
2024 Sep 09, 3:47pm | 633Shares of Rocket Pharmaceuticals (NASDAQ: RCKT) have plunged 32.9% in the past six months compared with the industry's decline of 3.4%. The company is developing its gene therapy candidate, Kresladi (marnetegragene autotemcel) to treat patients with severe leukocyte adhesion deficiency-I (LAD-I...
-
Virco Manufacturing Corporation Surpasses Q2 Earnings Estimates
2024 Sep 09, 2:26pm | 641Virco Manufacturing Corporation (NASDAQ: VIRC) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $1 per share. This compares to earnings of $0.95 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an...
-
IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab
2024 Sep 09, 2:08pm | 912Shares of Immunovant (NASDAQ: IMVT) are rising in the pre-market hours on Sept. 9 after the company announced positive data from the mid-stage study of its investigational candidate, batoclimab, which is being developed for Graves' Disease. IMVT's Batoclimab Shows Superior Efficacy in GD...
Coverage of Earnings Beats.